Introduction
Six X-linked (XL)' immunodeficiencies (ID) have so far been characterized. In XL chronic granulomatous disease (CGD), 1 . Abbreviations used in this paper: CGD, chronic granulomatous disease; E+, E rosette positive; ID, immunodeficiency; MLR, mixed leukocyte reaction; NBT, nitroblue tetrazolium; RFLP, restriction fragment length polymorphism; SCID, severe combined immunodeficiency, WAS, Wiskott-Aldrich syndrome; XL, X-linked; XLA, X-linked agammaglobulinemia.
granulocytes and monocytes are unable to kill microorganisms because of a cytochrome , chain defect (1, 2) . XL agammaglobulinemia (XLA) is due to an early arrest in B-cell maturation; the abnormal (unknown) gene is localized in Xq2 1.3-22 (3) . XL severe combined immunodeficiency (SCID) is characterized by an absence of T lymphocytes, the abnormal locus being mapped in Xql3 (4) . Hyper-IgM syndrome with low IgG and IgA is an Ig switch defect, the locus of which has been mapped to . XL lymphoproliferative syndrome is characterized by an abnormal susceptibility to Epstein-Barr virus (EBV) infection, the gene being localized in Xq25 (6) . Finally, Wiskott-Aldrich syndrome (WAS) is associated with platelet anomalies and has been mapped around Xpl 1.2 (7, 8) .
In this study, we report clinical, immunological, and genetic findings pertaining to a family in which several males have been affected by a T-and B-cell functional ID that does not correspond to any known XL form. This syndrome may represent either a new XL ID or an attenuated phenotype of XL SCID.
Methods
Immunologic investigations. Peripheral blood mononuclear cells (PBMC) and polymorphonuclear cells (PMN) were isolated from freshly drawn heparinized blood by means ofFicoll Hypaque (Pharmacia Fine Chemicals, Uppsala, Sweden) density centrifugation.
Fluorescence staining was performed on PBMC. The following monoclonal antibodies (MAbs) were used: anti-CD3, Leu4 (IgG2a) ( Proliferation assays were performed as described elsewhere (9), using either mitogens in 4-d cultures or antigen and allogeneic cells in 6-d cultures. OKT3 antibody (50 ng/ml) (Ortho Diagnostic Systems, Inc., Raritan, NJ); anti-CD2 antibody pairs, D66 + Tl 1.1 antibody (10) (final dilution 1/200) kindly provided by A. Bernard, CHRU, Nice, France; and phytohemagglutinin (PHA) (Difco, Inc., Detroit, MI) (final dilution 1/700) were used as mitogens. Specific T-cell proliferation was driven by tetanus toxoid (Pasteur Institut, Marne la Coquette, France; final dilution 1/250). Candidin (Pasteur Institut; 10 Ig/ml), or allogeneic cells.
DNA analysis. Total genomic DNA was extracted from E-rosettepositive (E+) peripheral blood cells, PMN or Epstein-Barr virus-induced B cell lines (1 1, 12) . The B cell lines were obtained by pooling three to five low-passage (1 mo) B-lymphoblastoid cultures. DNA puri-fication and hybridization with radiolabeled probes were performed as previously described (13) . T-cell receptor rearrangement was performed using the cDNA TB constant region (14) and the Jy1 probe (pH60) (15) on EcoRI HindIII-and KpnI-digested E+-extracted DNA. Restriction fragment length polymorphism (RFLP) analysis was performed on Pstl-or Taqi-digested DNA with appropriate polymorphic X chromosome markers. X chromosome inactivation studies were performed as previously described (16) . Briefly, 20 ;g of DNA was digested with PstI and BstXI and divided into two I0-gg aliquots, one of which was further digested with 10 U of HpaII. Southern blotting was then performed with the phosphoglycerate kinase pSPTl9. 1 polymorphic probe (17) and the hypervariable marker DXS255 (18) .
Case report. The patient (III6 in Fig. 1 In addition, a maternal uncle (II8) had died at the age of 5 yr after repeated bouts ofbronchopneumonitis with bronchiectasia, skin infections, protracted diarrhea, and failure to thrive. Postmortem examination revealed similar findings to those in case 1112. Two of his brothers (II3 and 4) had died at the ages of 8 and 10 mo with severe diarrhea.
Results
Immunological investigations. As shown in Table II , except for the first 4 mo oflife, the patient had normal numbers ofT and B lymphocytes and natural killer cells. The distribution of cell subsets was unremarkable. HLA class I and class II antigens were normally expressed. In contrast, T-cell function progressively declined (Fig. 2) : antigen-induced T-cell proliferation to tetanus toxoid and Candida antigens, normal during the 1st yr of life, became negative despite two immunization shots with tetanus toxoid (Fig. 2) . Similarly, MLR activity was very low (Table II) and cytotoxic T-cell responses were absent (not shown), whereas mitogen-induced T-cell responses were present (Table II) . In vivo delayed-type skin hypersensitivity to Candida antigens was absent at 18 mo. Antibody responses that were first present to poliovirus and tetanus toxoid progressively disappeared (Fig. 3) . A slight anmnestic response to tetanus toxoid was evoked after an immunization shot (Fig. 3) . In addition, antibodies to Bordetella pertussis and diphtheria tox- performed. It has previously been shown that obligate carriers of three X-linked ID (XL SCID, XLA, and WAS) exhibit a nonrandom pattern of inactivation in some or all leukocyte subsets (19) (20) (21) (22) (23) . The X chromosome inactivation study was based on the differential methylation ofthe inactivated X chromosome by using RFLP markers, the pSPT 19-1 probe from the PGK locus and the hypervariable locus DXS255. These probes detect RFLP after double digestion of human genomic DNA with the enzymes BstXI and PstI. The use of the methylation-sensitive enzyme HpaII discriminates the inactivated allele (16) . Among the five female subjects studied (Il, II5, 1114, 5, 7 in Fig. 4 ) a polymorphism was detected with pSTPl9.1 in four. The mother of the propositus (II5) was informative with the DXS255 marker. The validation of the use of the DSX255 marker in X inactivation studies was previously performed by the study of X inactivation pattern in 47 females. They displayed identical X inactivation pattern with this probe compared to the pSTPl 9. 1 probe specific for the PGK gene. Fig. 4 A, the patient's sister II15 exhibited a random pattern of X inactivation in E(+), PMN, and EBV B cells. In contrast, her sister II17 (Fig. 4 A) and mother 115 ( T lymphocytes and EBV cell line but random inactivation in PMN. The two other female subjects, the sister 1117 and the grandmother Il (Fig. 4 A) show marked skewing in all cells subsets. Such extreme Iyonization can be observed in a low percentage of normal female (22) probably dependent on the number of cells present at the time of X inactivation. A thin upper band can, however, be observed in the PMN subset of these two subjects after HpaII addition; this band is absent in the T cell population. Densitometric analysis (Fig. 4 A) indicates that the same X is always active in 100% of the T cells, and in at least 95% ofthe PMN, the other X being active in 0% of the T cells and 5% of the PMN. This difference, which was observed twice in two different experiments, is however too small to draw definitively conclusions on the carrier status and on the affected cells in these two women. Nevertheless, it is interesting to note that in each ofthe four female subjects presenting a nonrandom pattern of X inactivation, the inactivated X chromosome is the same as the one transmitted to the propositus. As shown in Fig. 4 A, although the 1.05-kb allele of PGK was undetectable in the E+ cell populations of sister I117, a very thin band persisted in the B cells as shown by densitometric analysis (Fig. 4 A) . This suggests that the second X chromosome was not inactivated in all B cells. The segregation of five polymorphic markers spanning the X chromosome was studied in the family. Their gene sequence was X-ter-DXS255-cent-DXSl 59-PGK-DXYS2X-DXS94 (25) . It was possible to trace the two haplotypes defined in the grandmother (Il) into her progeny. Interestingly, the haplotype expressed by the patient was also detected in his two sisters who exhibited a nonrandom X chromosome inactivation pattern. In each of the four female subjects concerned, the inactivated X chromosome was the same as the one transmitted to the propositus (Fig. 4) . Conversely, the second haplotype was found in the unaffected maternal uncle of the propositus (117).
In the patient's sister 1115, a recombination was detected between DXS 159 and DXYS2X. Since the pattern ofthe X chromosome inactivation was random in this subject, it indicates that the disease locus most probably resides proximal to the region DXYS2X.
Discussion
The patient studied in this work presents evidence for a persisting T and B cell immunodeficiency characterized by low and declining antigen-specific responses in vivo and in vitro. This was associated with progressively intractable diarrhea. Given the family history and the absence of evidence for an acquired immunodeficiency, it seems probable that this child was suffering from an inherited immune defect.
The fact that two brothers and at least one maternal uncle were similarly affected pointed to a recessive XL inheritance. This was confirmed by the lack of any immune deficiency in the female members of the family and by the nonrandom X inactivation pattern found in the grandmother, the mother and two ofthe three sisters. The patient presented none ofthe characteristics of the known X immunodeficiencies. Indeed, a normal NBT test result ruled out CGD (26, 27) , and the presence of polyclonal hypergammaglobulinemia was inconsistent with XLA and the hyper-IgM syndrome (28, 29) . The clinical and immunological presentation was also inconsistent with XL lymphoproliferative syndrome (6) , in that clinical manifestations appeared very early in life and were not those encountered in XL lymphoproliferative syndrome (aplastic anemia, lymphoma, hepatitis, or hypogammaglobulinemia). In addition, no serum antibody to EBV could be detected in the patient and EBV was not found in blood mononuclear cells by Southern blot hybridization. WAS was unlikely because there were no quantitative or qualitative platelet abnormalities, no history of eczema and normal IgM levels. In addition, the X inactivation pattern in the carriers did not correspond to that observed in WAS carriers, i.e., nonrandom X inactivation in all leukocytes (22, 23) . Finally, XL SCID, characterized by low T-cell counts and normal or increased B-cell counts (30), did not fit this case because of the presence of a normal number of T cells (except during the first 4 mo of life) that were partially functional and were not of maternal origin. We therefore hypothesized the occurrence of a previously undescribed Xlinked immunodeficiency in this family. This syndrome is characterized by functional defects of both T and B cells, the molecular origin of which is unknown. The obligate carrier's mother exhibits a nonrandom X inactivation in T and B lymphocytes, as in XL SCID carriers (1 9, 20) , indicating that the gene product of the disease locus is necessary for the normal development of T and B cells (31) . Taking into account the results of the inactivation studies for the determination of the carrier status of the sisters, RFLP analysis indicated that the gene locus probably maps above DXYS2X (given the recombination found in sister 1115).
Two types ofmolecular defect could account for this immunodeficiency. First, it might result from the mutation of an unknown and new XL gene involved in T/B lymphocyte differentiation and function. Secondly, and more probably, it might be the consequence of a different mutation of the XL SCID locus. This latter hypothesis is based on the T-and B-cell dysfunctions observed, together with an X inactivation pattern in the carriers identical to that in XL SCID carriers (19, 20) . In addition, RFLP findings were consistent with a mutation in the proximal Xq region near PGK similar to that in XL-SCID (4), but did not rule out a locus on the short arm. Interestingly, another XL combined immunodeficiency has been recently described, in one family over three generations (32) . However, in this family, patients survived postinfancy or even into adulthood. This suggests a less severe form of immunodeficiency. These patients also displayed normal concentration of immunoglobulines except for an elevated IgE, poorly functional T cells, and absence of diphtheria toxoid antibody response contrasting with a rise in Candida albicans antibody (32) . It would thus be interesting to know the results of RFLP study in this pedigree.
There have been other examples of immune defects thought to be attenuated XL forms. Indeed, some XLA patients have B cells with residual immunoglobulin production; no evidence for another locus was detected in segregation studies (33) . In addition, XL thrombocytopenia might be an attenuated form of WAS, inasmuch as the encoding gene maps to the same region as that of WAS (34) .
Further characterization of the molecular defect responsible for the novel XL immunodeficiency that we describe may contribute to our understanding ofthe role of XL genes in T/B cell differentiation and function.
